
Dameron Levest Jones
Examiner (ID: 2158, Phone: (571)272-0617 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1621, 1622, 1211, 3991, RD00, 1615, 1619, 1616, 1618 |
| Total Applications | 2556 |
| Issued Applications | 1513 |
| Pending Applications | 397 |
| Abandoned Applications | 681 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19491587
[patent_doc_number] => 12110283
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-08
[patent_title] => Carbonic anhydrase targeting agents and methods of using same
[patent_app_type] => utility
[patent_app_number] => 17/372029
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 23409
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17372029
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/372029 | Carbonic anhydrase targeting agents and methods of using same | Jul 8, 2021 | Issued |
Array
(
[id] => 17140274
[patent_doc_number] => 20210308285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => HSP90-TARGETED INFLAMMATION AND INFECTION IMAGING AND THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/349723
[patent_app_country] => US
[patent_app_date] => 2021-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18743
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17349723
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/349723 | HSP90-TARGETED INFLAMMATION AND INFECTION IMAGING AND THERAPY | Jun 15, 2021 | Abandoned |
Array
(
[id] => 17805965
[patent_doc_number] => 20220257800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => SELECTIVE DELIVERY MOLECULES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/302453
[patent_app_country] => US
[patent_app_date] => 2021-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17302453
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/302453 | SELECTIVE DELIVERY MOLECULES AND METHODS OF USE | May 2, 2021 | Abandoned |
Array
(
[id] => 17183937
[patent_doc_number] => 20210330822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => FLUORESCENT PROBE FOR CYCLOOXYGENASE-2
[patent_app_type] => utility
[patent_app_number] => 17/240427
[patent_app_country] => US
[patent_app_date] => 2021-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17240427
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/240427 | Fluorescent probe for cyclooxygenase-2 | Apr 25, 2021 | Issued |
Array
(
[id] => 17441943
[patent_doc_number] => 20220062448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/236844
[patent_app_country] => US
[patent_app_date] => 2021-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18074
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -58
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17236844
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/236844 | COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME | Apr 20, 2021 | Abandoned |
Array
(
[id] => 19265344
[patent_doc_number] => 20240209043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => NON-ANTIBODY BINDING PEPTIDES AND THEIR ANALOGS DUAL-TARGETING TO PD-1 AND PD-L1, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/908262
[patent_app_country] => US
[patent_app_date] => 2021-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7150
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908262
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/908262 | NON-ANTIBODY BINDING PEPTIDES AND THEIR ANALOGS DUAL-TARGETING TO PD-1 AND PD-L1, AND USES THEREOF | Apr 15, 2021 | Pending |
Array
(
[id] => 17126246
[patent_doc_number] => 20210301014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => MULTI-SPECIFIC ANTIBODIES WITH AFFINITY FOR HUMAN A33 ANTIGEN AND DOTA METAL COMPLEX AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/229007
[patent_app_country] => US
[patent_app_date] => 2021-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30933
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17229007
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/229007 | Multi-specific antibodies with affinity for human A33 antigen and DOTA metal complex and uses thereof | Apr 12, 2021 | Issued |
Array
(
[id] => 19456795
[patent_doc_number] => 12097264
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-24
[patent_title] => Methods and compositions for theranostic nanoparticles
[patent_app_type] => utility
[patent_app_number] => 17/228286
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 50
[patent_no_of_words] => 35133
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17228286
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/228286 | Methods and compositions for theranostic nanoparticles | Apr 11, 2021 | Issued |
Array
(
[id] => 18496218
[patent_doc_number] => 20230218783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/212878
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18183
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -58
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17212878
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/212878 | COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME | Mar 24, 2021 | Abandoned |
Array
(
[id] => 17297968
[patent_doc_number] => 20210393807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => PHOTOACOUSTIC VOLTAGE-SENSITIVE DYES FOR IN VIVO IMAGING
[patent_app_type] => utility
[patent_app_number] => 17/194649
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26042
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194649
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/194649 | PHOTOACOUSTIC VOLTAGE-SENSITIVE DYES FOR IN VIVO IMAGING | Mar 7, 2021 | Abandoned |
Array
(
[id] => 18284224
[patent_doc_number] => 20230099696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => NANO-COMPOSITE MICROPARTICLES OF POLYMYXIN
[patent_app_type] => utility
[patent_app_number] => 17/908492
[patent_app_country] => US
[patent_app_date] => 2021-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9050
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908492
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/908492 | NANO-COMPOSITE MICROPARTICLES OF POLYMYXIN | Mar 4, 2021 | Pending |
Array
(
[id] => 18552424
[patent_doc_number] => 20230250433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => METHODS AND COMPOSITIONS FOR TREATMENT OF APC-DEFICIENT CANCER
[patent_app_type] => utility
[patent_app_number] => 17/905124
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23324
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905124
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905124 | METHODS AND COMPOSITIONS FOR TREATMENT OF APC-DEFICIENT CANCER | Feb 25, 2021 | Pending |
Array
(
[id] => 16898905
[patent_doc_number] => 20210177821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => Androgen Receptor Modulator And Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/185420
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30812
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17185420
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/185420 | Androgen Receptor Modulator And Uses Thereof | Feb 24, 2021 | Abandoned |
Array
(
[id] => 18589227
[patent_doc_number] => 11738099
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-29
[patent_title] => Molecular probes and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/182997
[patent_app_country] => US
[patent_app_date] => 2021-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 44
[patent_no_of_words] => 26730
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182997
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/182997 | Molecular probes and methods of use | Feb 22, 2021 | Issued |
Array
(
[id] => 16932307
[patent_doc_number] => 20210198196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => NON-AGGREGATING HEPTAMETHINE CYANINE FLUOROPHORES FOR IN VIVO IMAGING
[patent_app_type] => utility
[patent_app_number] => 17/179217
[patent_app_country] => US
[patent_app_date] => 2021-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15756
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17179217
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/179217 | Non-aggregating heptamethine cyanine fluorophores for in vivo imaging | Feb 17, 2021 | Issued |
Array
(
[id] => 18252718
[patent_doc_number] => 20230079757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => METHODS AND MATERIALS FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/800008
[patent_app_country] => US
[patent_app_date] => 2021-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15825
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17800008
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/800008 | METHODS AND MATERIALS FOR TREATING CANCER | Feb 17, 2021 | Pending |
Array
(
[id] => 17065917
[patent_doc_number] => 20210268132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => METHODS OF SEQUESTERING TARGET ELEMENTS
[patent_app_type] => utility
[patent_app_number] => 17/175228
[patent_app_country] => US
[patent_app_date] => 2021-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22632
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17175228
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/175228 | METHODS OF SEQUESTERING TARGET ELEMENTS | Feb 11, 2021 | Pending |
Array
(
[id] => 17050767
[patent_doc_number] => 20210260201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => EXTRACELLULAR VESICLES FOR THE TREATMENT AND PREVENTION OF INFECTIONS AND OTHER DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/172293
[patent_app_country] => US
[patent_app_date] => 2021-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17851
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17172293
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/172293 | EXTRACELLULAR VESICLES FOR THE TREATMENT AND PREVENTION OF INFECTIONS AND OTHER DISEASES | Feb 9, 2021 | Abandoned |
Array
(
[id] => 16992172
[patent_doc_number] => 20210230592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => Targeted Self-Assembly of Functionalized Carbon Nanotubes on Tumors
[patent_app_type] => utility
[patent_app_number] => 17/158132
[patent_app_country] => US
[patent_app_date] => 2021-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11544
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17158132
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/158132 | Targeted Self-Assembly of Functionalized Carbon Nanotubes on Tumors | Jan 25, 2021 | Abandoned |
Array
(
[id] => 16822797
[patent_doc_number] => 20210138090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => uPAR targeting peptide for use in peroperative optical imaging of invasive cancer
[patent_app_type] => utility
[patent_app_number] => 17/150133
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17150133
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/150133 | uPAR targeting peptide for use in peroperative optical imaging of invasive cancer | Jan 14, 2021 | Abandoned |